Vivek Venkataramani

11PUBLICATIONS
46CO-AUTHORS
Predictive and prognostic markersMolecular targetsMedical infection agents (incl. prions)Nuclear engineering (incl. fuel enrichment and waste processing and storage)Metabolic medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Aug 06, 2025
Impact of Baseline β-Catenin Comutations on Prognosis in EGFR-Mutant Lung Cancer.

Jonas Kulhavy, Katja Maurus, Miriam Blasi

|Jul 31, 2024
Rapid response to selpercatinib in RET fusion positive pancreatic neuroendocrine carcinoma confirmed by smartwatch.

Barbara Deschler-Baier, Markus Krebs, Matthias Kroiss

|Aug 04, 2023
Ferroptosis contributes to multiple sclerosis and its pharmacological targeting suppresses experimental disease progression.

Emily Van San, Angela C Debruyne, Geraldine Veeckmans

|Mar 11, 2023
Editorial to the Special Issue "Homeostasis: Metals and Cellular Redox and Immunity Status".

Bernhard Michalke, Vivek Venkataramani

|Nov 10, 2021
Extracellular vesicles from hypoxia-preconditioned microglia promote angiogenesis and repress apoptosis in stroke mice via the TGF-β/Smad2/3 pathway.

Lin Zhang, Wei Wei, Xiaoyu Ai

|Oct 20, 2021
The glucose-sensing transcription factor MLX balances metabolism and stress to suppress apoptosis and maintain spermatogenesis.

Patrick A Carroll, Brian W Freie, Pei Feng Cheng

Pageof 2

Frequent Collaborators

2 joint publications

Gerburg M Wulf

2 joint publications

Bernhard Michalke

1 joint publications

Ashley I Bush

1 joint publications

Airton Cunha Martins